Please login to the form below

Not currently logged in


This page shows the latest pomalidomide news and features for those working in and with pharma, biotech and healthcare.

Celgene’s triple multiple myeloma therapy clears phase III trial

Celgene’s triple multiple myeloma therapy clears phase III trial

expanding role of pomalidomide in previously treated multiple myeloma patients.”. ... Pomalyst (pomalidomide) - Celgene’s second biggest earner - brought in $1.6bn for the biotech last year, an increase of 23% from $1.3bn seen in 2016.

Latest news

More from news
Approximately 6 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....